| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Bailey Gregory is a Director at SER, with reported holdings spanning 2 companies. Recent filings cover 23 purchases and 0 sales. Those positions are worth an estimated $53.1M at current prices.
Our model assigns Bailey Gregory a below-average insider score of 41/100, based on 22 past trades. Over a 12-month horizon, 9.5% of those trades were profitable, with an average 12-month return of -23.3%.
Bailey Gregory's largest disclosed position is in BHVN as Director, worth about $29.3M. Net of sales, the recent Form 4 record there shows accumulation of 712,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | BHVN Biohaven Ltd. | Director | Buy | 400,000 | $7.50 | $3,000,000.00 | +24.7% | +45.8% | - | |
| Dec 17, 2024 | SER Serina Therapeutics, Inc. | Director | Buy | 3,866 | $4.59 | $17,744.55 | +6.1% | -8.2% | -38.6% | |
| Sep 24, 2024 | BHVN Biohaven Ltd. | Director | Buy | 5,000 | $44.19 | $220,966.00 | +0.3% | -19.7% | -69.5% | |
| Sep 20, 2024 | SER Serina Therapeutics, Inc. | Director | Buy | 1,137 | $6.03 | $6,851.45 | +1.8% | -16.4% | -24.0% | |
| Sep 19, 2024 | SER Serina Therapeutics, Inc. | Director | Buy | 14,388 | $6.13 | $88,257.39 | +14.6% | +2.9% | -15.6% | |
| Aug 20, 2024 | SER Serina Therapeutics, Inc. | Director | Buy | 1,776 | $8.25 | $14,652.00 | +3.9% | -39.4% | -37.0% | |
| Aug 19, 2024 | SER Serina Therapeutics, Inc. | Director | Buy | 19,200 | $7.30 | $140,116.48 | +19.4% | -38.2% | -38.1% | |
| Aug 14, 2024 | SER Serina Therapeutics, Inc. | Director | Buy | 6,400 | $7.07 | $45,228.16 | +31.7% | -24.1% | -19.6% | |
| May 30, 2024 | SER Serina Therapeutics, Inc. | Director | Buy | 6,378 | $9.50 | $60,591.00 | +22.1% | -17.4% | -36.8% | |
| May 28, 2024 | SER Serina Therapeutics, Inc. | Director | Buy | 9,019 | $9.50 | $85,680.50 | +187.5% | -16.6% | -40.2% |